Manuel Hernández González I am immunologist with experience in primary immunodeficiencies and pathologies of the complement system who, in addition to developing the care, teaching and research functions typical of the area of knowledge, I have carried out and carry out tasks related to training, quality and process management. I currently develop my activity as head of the immunology service. Institutions of which they are part Translational Immunology Vall Hebron Institut de Recerca Head of Department Immunology Cross-departmental services LinkedIn Orcid Email Manuel Hernández González LinkedIn Orcid Email Institutions of which they are part Translational Immunology Vall Hebron Institut de Recerca Head of Department Immunology Cross-departmental services I am immunologist with experience in primary immunodeficiencies and pathologies of the complement system who, in addition to developing the care, teaching and research functions typical of the area of knowledge, I have carried out and carry out tasks related to training, quality and process management. I currently develop my activity as head of the immunology service.
Since 2017 I have been the head of the immunology service. I have more than thirty years of experience as an immunologist and also experience in the coordination of improvement programs, in providing methodological support in matters of quality of care, in the use of tools for the design of strategic and functional plans and in process management. Master in Direction and Management of Clinical Laboratories. UAB (2000). I have worked in cellular immunology until 2009 and in immunoproteins from 2010 to the present. I am secretary of the clinical committee for primary immunodeficiencies, vice-president of the subcommittee for the personalization of pharmacological treatments and a member of the clinical committee for complex glomerulopathies. Elected member of the Clinical Board 2022-2024. Member of the In Vitro Diagnosis Commission of the HUVH (2015-). I have participated in quality issues as a member of the Quality Committee of the VH Clinical Laboratories (LCVH) (2011-May 2016), member of the HUVH Quality Support Center (2004-2007) and I have been accredited since 2012 as an auditor Technical Expert in Diagnostic Immunology by ENAC (ISO-15189). I am the president of the LCVH Teaching and Training Commission since June 2017 and a member (2013-16), Tutor of Immunology residents (2011-16), associate professor of the Immunology knowledge area of the Department of Cell Biology, UAB Physiology and Immunology since December 2007, Coordinator of the "Immunodeficiencies" module from 2011 to 2017 and of "Immunopathology" and "Autoimmunity" of the Master's Degree in Advanced Immunology at the UAB-UB from 2021 to the present. I am a doctor in Biology (1996) and a researcher in the "complement pathology" line of the VHIR Traslacional Immunology research group. Coordinator of the immunochemistry working group of the Spanish Society of Immunology (SEI) from 2015 to 2020 and member of the Board of the SEI from 2020 to the present
Projects Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos. IP: Magda Campins Martí Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Laia Pinos Tella, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Blanca Borras Bermejo, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil Funding agency: Instituto de Salud Carlos III Funding: 73205 Reference: PI18/01887 Duration: 01/01/2019 - 30/06/2023 Caracterización clínica de variantes patogénicas e investigación de nuevos factores pronósticos en la nefropatía IgA IP: - Collaborators: Manuel Hernández González, Clara Carnicer Cáceres, Maria Teresa Salcedo Allende Funding agency: Instituto de Salud Carlos III Funding: 90750 Reference: PI10/01055 Duration: 01/01/2011 - 31/12/2013 Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH) IP: Rafael Simó Canonge Collaborators: Manuel Hernández González, Joan Montaner Villalonga, Mercè Boada Rovira, Ramon Charco Torra, José García Arumí, Albert Pahissa Berga, Josep Sánchez de Toledo Codina, Juan Lorente Guerrero, Miquel Casas Brugué, Monica Anglada Baguena, Miguel Vilardell Tarres, Sara Marsal Barril, Joan Sahuquillo Barris, Cristina Hernández Pascual, Ester Carceller Delgado, Xavier Montalban Gairín Funding agency: Instituto de Salud Carlos III Funding: 781267.51 Reference: CAI08/01/0034 Duration: 01/01/2009 - 31/12/2012 Estudio de factores etiológicos y moduladores del fenotipo inmunológico y de la evolución clínica en pacientes con déficit de iga e inmunodeficiencia variable común IP: - Collaborators: Manuel Hernández González Funding agency: Instituto de Salud Carlos III Funding: 49450 Reference: SAF2004-03495 Duration: 13/12/2004 - 13/12/2007 Pagination First page « Previous page ‹ Page 1 Current page 2